Previous terms
continue: When four years of data are available, CMS will evaluate
the within-plan temporal variability in quality scores available to
consumers and adjust the frequency of the data collection
accordingly. If there is very little change in the quality scores
across time, CMS will consider collecting the information less
frequently and present a report to OMB.
Inventory as of this Action
Requested
Previously Approved
12/31/2023
36 Months From Approved
12/31/2020
43,872
0
56,972
9,354
0
12,754
0
0
0
This information collection will
survey disenrollees from Medicare Prescription Drug Plans (PDPs)
and Medicare Advantage Prescription Drug Plans (MA-PDs). The
Medicare Prescription Drug, Improvement, and Modernization Act of
2003 (MMA) provides a requirement to collect and report performance
data for Part D prescription drug plans. Specifically, the MMA
under Sec. 1860D-4 (Beneficiary Protections for Qualified
Prescription Drug Coverage) requires CMS to conduct consumer
satisfaction surveys regarding PDPs and MA-PDs - pursuant to
section 1860D-4(d). This data collection complements the
satisfaction data collected through the Medicare CAHPS Survey by
providing dissatisfaction data in the form of reasons for
disenrollment from PDPs and MA-PDs.
Statute at
Large: 1
Stat. 1860 Name of Statute: null
The proposed revisions reduce
our estimated completion time per survey from 12 to 11 minutes for
PDP survey responses, and from 14 to 13 minutes for MA responses.
On an annualized basis, the estimate of respondent burden is also
reduced from the estimate provided in our 2017 OMB application due
to a reduction in response rates from ~40% (2017 OMB application
assumption) to ~30% (based on observed response rates for the
survey in years 2016 and 2017). Total burden has decreased from
12,754 to 9,354.
Stephan McKenzie 410 786-1943
stephan.mckenzie@cms.hhs.gov
No
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.